Patent · US Active

Compounds for preparing immunological adjuvant

US7683200B2 · kind B2 · utility

8Cited by
4References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 30, 2006
Grant dateMar 23, 2010
Priority date
Expiry dateAug 3, 2027

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/55
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention provides methods for preparing TLR-4 receptor agonist E6020:and stereoisomers thereof, which compounds are useful as an immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases. Also provided are synthetic intermediates.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.